0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Pediatric Forum |

Declining Early Childhood Mortality From Invasive Pneumococcal Disease: The Impact of Vaccination

Matthew D. Redelings, MPH; Frank Sorvillo, PhD; Paul Simon, MD, MPH; Laurene Mascola, MD, MPH
Arch Pediatr Adolesc Med. 2005;159(2):195-197. doi:10.1001/archpedi.159.2.195-c.
Text Size: A A A
Published online

Extract

Invasive pneumococcal disease (IPD) is an important cause of morbidity and mortality in young children. In 2000, a 7-valent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for IPD prevention in children.1 Subsequent decreases in IPD incidence in young children have been noted.2,3 However, population-based data are lacking on the impact of PCV7 on early childhood mortality. We used vital records data to assess the effects of PCV7 on mortality in children younger than 2 years in the United States.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.

Crude invasive pneumococcal disease (IPD) mortality rates per 100 000 population by year in children younger than 2 years in the United States, 1995 to 2001.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();